Cargando…

Chemoprevention for the Populations of Malaria Endemic Africa

Drugs have been used to prevent malaria for centuries, but only recently have they been used on a large scale to prevent malaria in the resident population of malaria endemic areas in sub-Saharan Africa. This paper discusses some of the reasons for the hesitancy in adoption of chemopreventive strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenwood, Brian, Schellenberg, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680511/
https://www.ncbi.nlm.nih.gov/pubmed/36412595
http://dx.doi.org/10.3390/diseases10040101
_version_ 1784834435837853696
author Greenwood, Brian
Schellenberg, David
author_facet Greenwood, Brian
Schellenberg, David
author_sort Greenwood, Brian
collection PubMed
description Drugs have been used to prevent malaria for centuries, but only recently have they been used on a large scale to prevent malaria in the resident population of malaria endemic areas in sub-Saharan Africa. This paper discusses some of the reasons for the hesitancy in adoption of chemopreventive strategies in sub-Saharan Africa, reasons why this hesitancy has been overcome in recent years and the range of target groups now identified by the World Health Organization as those who can benefit most from chemoprevention. Adoption of carefully targeted chemopreventive strategies could help reverse the recent stagnation in the decline in malaria in sub-Saharan Africa that had been taking place during the previous two decades.
format Online
Article
Text
id pubmed-9680511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96805112022-11-23 Chemoprevention for the Populations of Malaria Endemic Africa Greenwood, Brian Schellenberg, David Diseases Commentary Drugs have been used to prevent malaria for centuries, but only recently have they been used on a large scale to prevent malaria in the resident population of malaria endemic areas in sub-Saharan Africa. This paper discusses some of the reasons for the hesitancy in adoption of chemopreventive strategies in sub-Saharan Africa, reasons why this hesitancy has been overcome in recent years and the range of target groups now identified by the World Health Organization as those who can benefit most from chemoprevention. Adoption of carefully targeted chemopreventive strategies could help reverse the recent stagnation in the decline in malaria in sub-Saharan Africa that had been taking place during the previous two decades. MDPI 2022-11-08 /pmc/articles/PMC9680511/ /pubmed/36412595 http://dx.doi.org/10.3390/diseases10040101 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Greenwood, Brian
Schellenberg, David
Chemoprevention for the Populations of Malaria Endemic Africa
title Chemoprevention for the Populations of Malaria Endemic Africa
title_full Chemoprevention for the Populations of Malaria Endemic Africa
title_fullStr Chemoprevention for the Populations of Malaria Endemic Africa
title_full_unstemmed Chemoprevention for the Populations of Malaria Endemic Africa
title_short Chemoprevention for the Populations of Malaria Endemic Africa
title_sort chemoprevention for the populations of malaria endemic africa
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680511/
https://www.ncbi.nlm.nih.gov/pubmed/36412595
http://dx.doi.org/10.3390/diseases10040101
work_keys_str_mv AT greenwoodbrian chemopreventionforthepopulationsofmalariaendemicafrica
AT schellenbergdavid chemopreventionforthepopulationsofmalariaendemicafrica